Abstract Background: Cholinesterase inhibitors are modestly effective in treating patients with Alzheimer’s disease. However, there may be important inter-individual variations ranging from no improvement at all to significant improvement and long periods of stabilization. Carotid atherosclerosis is associated with cognitive decline in elderly people. Objective: The objective of this study was to investigate whether carotid intima-media thickness (IMT) predicts response to cholinesterase inhibitors in Alzheimer’s disease. Patients and methods: A series of 54 patients with mild to moderate Alzheimer’s disease were enrolled consecutively in an open-label trial. At baseline, all patients were assessed on the following clinical scales: Mini-Mental State Examination, Clinical Dementia Rating, the Hachinski Ischemic Scale, Blessed Dementia Rating Scale, Alzheimer’s Disease Assessment Scale-cognitive subscale (ADAS-cog), Neuropsychiatric Inventory (NPI) and a daily-living activities scale (Disability Assessment for Dementia [DAD]). Investigations included magnetic resonance imaging of the brain and a colour echo-Doppler scan of the carotid arteries to measure the maximum IMT. Patients were then commenced on galantamine treatment for 6 months, after which scores on the ADAS-cog, NPI and DAD scales were reassessed. Results: A total of 50 patients completed the study. Their mean age was 77.78 years (SD 6.51 years); 34 patients were female. Galantamine treatment decreased the mean NPI score from 17.68 to 13.86 points, but this difference was not statistically significant (p = 0.07). On the ADAS-cog scale, a modest and nonsignificant mean difference of −0.4 points (p = 0.7) was observed. A weak (correlation coefficient r = 0.4) but significant correlation between IMT and changes in clinical scale score was found, with low carotid IMT being shown to be a predictor of response on both the ADAS-cog (p = 0.003) and NPI (p = 0.006) scales; these findings were corroborated in multivariate analysis. For men, the correlation was stronger (r = 0.7 and 0.8 for the ADAS-cog and NPI scales, respectively). Conclusion: Although the magnitude of effect was moderate, carotid IMT could be a significant predictor of clinical response to cholinesterase inhibitors in patients with Alzheimer’s disease.
Dementia            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Dementia              

multivariate analysis         0.9992073876881513^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Multivariate_analysis 

scales                        0.9953287040860985^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Scale_(social_sciences)

disease                       0.9999089908278365^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Disease               

scales                        0.9953287040860985^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Scale_(social_sciences)

carotid arteries              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Common_carotid_artery 

Dementia                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Dementia              

DAD                           0.9991335959553013^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Disinhibited_attachment_disorder

correlation                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Correlation_and_dependence

brain                         0.9999999588433193^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Brain                 

cognitive                     0.9999999993719939^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cognition             

Dementia                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Dementia              

carotid                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Common_carotid_artery 

IMT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Intima-media_thickness

DAD                           0.9991335959553013^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Disinhibited_attachment_disorder

correlation                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Correlation_and_dependence

Galantamine                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Galantamine           

magnitude                     0.9984818553512473^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Magnitude_(astronomy) 

SD                            0.900420684753277^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/South_Dakota          

open-label trial              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Open-label_trial      

NPI                           0.9999999999174634^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/New_product_development

Cholinesterase inhibitors     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Acetylcholinesterase_inhibitor

IMT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Intima-media_thickness

disease                       0.9999089908278365^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Disease               

disease                       0.9999089908278365^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Disease               

IMT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Intima-media_thickness

correlation coefficient       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Correlation_and_dependence

disease                       0.9999089908278365^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Disease               

NPI                           0.9999999999174634^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/New_product_development

IMT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Intima-media_thickness

IMT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Intima-media_thickness

scales                        0.9953287040860985^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Scale_(social_sciences)

cholinesterase inhibitors     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Acetylcholinesterase_inhibitor

Blessed                       0.9999965325620085^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Beatification         

magnetic resonance imaging    0.9999999999874944^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Magnetic_resonance_imaging

scales                        0.9953287040860985^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Scale_(social_sciences)

carotid intima-media thickness1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Intima-media_thickness

cholinesterase inhibitors     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Acetylcholinesterase_inhibitor

NPI                           0.9999999999174634^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/New_product_development

atherosclerosis               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Atherosclerosis       

NPI                           0.9999999999174634^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/New_product_development

NPI                           0.9999999999174634^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/New_product_development

galantamine                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Galantamine           

Mini-Mental State Examination 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Mini–mental_state_examination

carotid                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Common_carotid_artery 

